vs
Side-by-side financial comparison of Organon & Co. (OGN) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× Virtu Financial, Inc.). Virtu Financial, Inc. runs the higher net margin — 31.6% vs -13.6%, a 45.2% gap on every dollar of revenue. On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (30.7% vs -5.3%). Over the past eight quarters, Virtu Financial, Inc.'s revenue compounded faster (25.7% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
OGN vs VIRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.1B |
| Net Profit | $-205.0M | $346.6M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 37.4% |
| Net Margin | -13.6% | 31.6% |
| Revenue YoY | -5.3% | 30.7% |
| Net Profit YoY | -288.1% | 82.8% |
| EPS (diluted) | $-0.78 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.5B | $969.9M | ||
| Q3 25 | $1.6B | $824.8M | ||
| Q2 25 | $1.6B | $999.6M | ||
| Q1 25 | $1.5B | $837.9M | ||
| Q4 24 | $1.6B | $834.3M | ||
| Q3 24 | $1.6B | $706.8M | ||
| Q2 24 | $1.6B | $693.0M |
| Q1 26 | — | $346.6M | ||
| Q4 25 | $-205.0M | $139.9M | ||
| Q3 25 | $160.0M | $77.6M | ||
| Q2 25 | $145.0M | $151.2M | ||
| Q1 25 | $87.0M | $99.7M | ||
| Q4 24 | $109.0M | $94.1M | ||
| Q3 24 | $359.0M | $60.0M | ||
| Q2 24 | $195.0M | $66.6M |
| Q1 26 | — | — | ||
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — |
| Q1 26 | — | 37.4% | ||
| Q4 25 | -9.8% | 35.4% | ||
| Q3 25 | 15.2% | 21.8% | ||
| Q2 25 | 14.4% | 34.7% | ||
| Q1 25 | 6.7% | 26.7% | ||
| Q4 24 | 8.1% | 24.3% | ||
| Q3 24 | 13.1% | 20.8% | ||
| Q2 24 | 14.6% | 22.4% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | -13.6% | 14.4% | ||
| Q3 25 | 10.0% | 9.4% | ||
| Q2 25 | 9.1% | 15.1% | ||
| Q1 25 | 5.8% | 11.9% | ||
| Q4 24 | 6.8% | 11.3% | ||
| Q3 24 | 22.7% | 8.5% | ||
| Q2 24 | 12.1% | 9.6% |
| Q1 26 | — | $1.99 | ||
| Q4 25 | $-0.78 | $1.54 | ||
| Q3 25 | $0.61 | $0.86 | ||
| Q2 25 | $0.56 | $1.65 | ||
| Q1 25 | $0.33 | $1.08 | ||
| Q4 24 | $0.42 | $1.03 | ||
| Q3 24 | $1.38 | $0.64 | ||
| Q2 24 | $0.75 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $973.2M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $2.2B |
| Total Assets | $12.9B | $25.1B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $973.2M | ||
| Q4 25 | $574.0M | $1.1B | ||
| Q3 25 | $672.0M | $707.9M | ||
| Q2 25 | $599.0M | $752.1M | ||
| Q1 25 | $547.0M | $723.6M | ||
| Q4 24 | $675.0M | $872.5M | ||
| Q3 24 | $763.0M | $701.4M | ||
| Q2 24 | $704.0M | $684.8M |
| Q1 26 | — | — | ||
| Q4 25 | $8.6B | $2.0B | ||
| Q3 25 | $8.8B | $2.0B | ||
| Q2 25 | $8.9B | $1.7B | ||
| Q1 25 | $9.0B | $1.7B | ||
| Q4 24 | $8.9B | $1.7B | ||
| Q3 24 | $8.7B | $1.7B | ||
| Q2 24 | $8.7B | $1.7B |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $752.0M | $1.6B | ||
| Q3 25 | $906.0M | $1.5B | ||
| Q2 25 | $733.0M | $1.4B | ||
| Q1 25 | $542.0M | $1.3B | ||
| Q4 24 | $472.0M | $1.3B | ||
| Q3 24 | $493.0M | $1.2B | ||
| Q2 24 | $144.0M | $1.2B |
| Q1 26 | — | $25.1B | ||
| Q4 25 | $12.9B | $20.2B | ||
| Q3 25 | $13.6B | $21.3B | ||
| Q2 25 | $13.5B | $19.3B | ||
| Q1 25 | $13.2B | $17.5B | ||
| Q4 24 | $13.1B | $15.4B | ||
| Q3 24 | $12.8B | $14.4B | ||
| Q2 24 | $12.2B | $13.9B |
| Q1 26 | — | — | ||
| Q4 25 | 11.49× | 1.29× | ||
| Q3 25 | 9.74× | 1.40× | ||
| Q2 25 | 12.14× | 1.24× | ||
| Q1 25 | 16.52× | 1.33× | ||
| Q4 24 | 18.81× | 1.39× | ||
| Q3 24 | 17.75× | 1.41× | ||
| Q2 24 | 60.11× | 1.41× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | — |
| Free Cash FlowOCF − Capex | $96.0M | — |
| FCF MarginFCF / Revenue | 6.4% | — |
| Capex IntensityCapex / Revenue | 3.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $141.0M | $518.4M | ||
| Q3 25 | $264.0M | $-68.7M | ||
| Q2 25 | $220.0M | $62.8M | ||
| Q1 25 | $75.0M | $15.0M | ||
| Q4 24 | $390.0M | $599.0M | ||
| Q3 24 | $141.0M | $112.1M | ||
| Q2 24 | $332.0M | $490.8M |
| Q1 26 | — | — | ||
| Q4 25 | $96.0M | $495.6M | ||
| Q3 25 | $218.0M | $-76.7M | ||
| Q2 25 | $181.0M | $57.6M | ||
| Q1 25 | $43.0M | $9.2M | ||
| Q4 24 | $335.0M | $586.6M | ||
| Q3 24 | $99.0M | $106.2M | ||
| Q2 24 | $300.0M | $486.9M |
| Q1 26 | — | — | ||
| Q4 25 | 6.4% | 51.1% | ||
| Q3 25 | 13.6% | -9.3% | ||
| Q2 25 | 11.4% | 5.8% | ||
| Q1 25 | 2.8% | 1.1% | ||
| Q4 24 | 21.0% | 70.3% | ||
| Q3 24 | 6.3% | 15.0% | ||
| Q2 24 | 18.7% | 70.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 2.4% | ||
| Q3 25 | 2.9% | 1.0% | ||
| Q2 25 | 2.4% | 0.5% | ||
| Q1 25 | 2.1% | 0.7% | ||
| Q4 24 | 3.5% | 1.5% | ||
| Q3 24 | 2.7% | 0.8% | ||
| Q2 24 | 2.0% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.71× | ||
| Q3 25 | 1.65× | -0.89× | ||
| Q2 25 | 1.52× | 0.42× | ||
| Q1 25 | 0.86× | 0.15× | ||
| Q4 24 | 3.58× | 6.37× | ||
| Q3 24 | 0.39× | 1.87× | ||
| Q2 24 | 1.70× | 7.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
VIRT
| Trading income, net | $789.1M | 72% |
| Commissions, net and technology services | $186.6M | 17% |
| Other | $119.6M | 11% |
